Judith U. Kim

Judith U. Kim: Attorney with Rubin and Rudman LLP
  • Partner at Rubin and Rudman LLP (69 Attorneys)
  • 800 Connecticut Ave., NW, 4th Floor, Washington, DC 20006
    View Judith U. Kim's office location
  • Peer Reviews

    No Reviews
  • Profile Visibility [ i ]


Judith Kim is a Partner in Rubin and Rudman’s Washington, DC office and Chair of the firm’s Intellectual Property Practice. For over 20 years, Judy has counseled clients innovating in pharmaceuticals, biotechnology, immunology, diagnostics, biofuel, agrosciences, food products, nutraceuticals, cosmetics and personal care. Judy’s practice includes:

• Preparation of patent applications and their prosecution and appeals worldwide

• Management of foreign oppositions and invalidation trials

• Contested proceedings before the U.S. Patent and Trademark Office

• Opinions on invalidity and noninfringement to ensure freedom to operate

• Due diligences for evaluation of investments and acquisitions, and agreements

Prior to joining Rubin and Rudman, Judy was a senior partner at a leading IP law firm, where she led legal teams in patent portfolio management, inter partes disputes, licensing and related IP counseling.

Judy’s scientific experience is in the areas of microbial and mammalian biology. She co-authored eleven publications resulting from her research.

Judy is an Adjunct Professor at Sogang University Law School in Korea. She speaks Korean.


LMG Euromoney - Life Sciences “Star” (2012-2015)


• Judith U. Kim and Scott A. Schaller, “IP Flash: Transformative Subject Matter Patent-Eligibility in the US,” European Biotechnology (2015)

• Judith U. Kim and Scott A. Schaller, “After Alice: The Two-Step Rule,” LSIPR Newsletter (2015)

• Judith U. Kim, Paul A. Calvo and Miklos Gaszner, “USPTO Issues New Subject Matter Eligibility Examination Guidelines for Claims Involving Laws of Nature, Natural Principles, Natural Phenomena, and/or Natural Products,” The National Law Review (2014)

• “Lawyers Weigh In On Supreme Court's Monsanto Ruling,” John Quinn, Law360 Intellectual Property (2013)

• Judith U. Kim, “Possible Far-Reaching Implications of Bowman v. Monsanto,” Intellectual Property Today (2013)

• Judith U. Kim and Jorge A. Goldstein, Ph.D., “In Oral Arguments during Bowman v. Monsanto the Supreme Court Struggles with Exhaustion Doctrine for Patented Seeds,” Sterne, Kessler, Goldstein & Fox (2013)

• Judith U. Kim and Katrina P. Quach, “Trade Secrets - Less Risky Under AIA Prior User Rights?,” Law360 Intellectual Property (2012)

• Eldora L. Ellison, Ph.D. and Judith U. Kim, “Patent Prosecution Strategies for Life Sciences Companies Under the AIA,” Bloomberg Law Reports - Intellectual Property (2012)

• Judith U. Kim and Paul A. Calvo, “Patent Rights From Stem Cell Research Funded By Proposition 71,” Sterne, Kessler, Goldstein & Fox P.L.L.C. (2005)

• Satoh T., Feng P., Kim U.J., Wilber J.F., “Identification of thyrotropin-releasing hormone receptor in the rat testis,” Neuropeptides 27:195-202 (1994)

• Satoh T., Feng P., Kim U.J., Wilber J.F., “Identification of thyrotropin-releasing hormone receptor messenger RNA in the rat central nervous system and eye,” Brain Res. Mol. Brain Res. 19:175-178 (1993)

• Feng P., Gu J., Kim U.J., Carnell N.E., Wilber J.F., “Identification, localization and developmental studies of rat prepro thyrotropin-releasing hormone mRNA in the testis,” Neuropeptides 24:63-69 (1993)

• Carnell N.E., Feng P., Kim U.J., Wilber J.F., “Preprothyrotropin-releasing hormone mRNA and TRH are present in the rat heart,” Neuropeptides 22:209-212 (1992)

• Wilber J.F., Yamada M., Kim U.J., Feng P., Carnell N.E., “The human prepro thyrotropin-releasing hormone (TRH) gene: cloning, characterization, hormonal regulation, and gene localization,” Trans. Am. Clin. Climatol. Assoc. 103:111-119 (1992)

• Feng P., Carnell N.E., Kim U.J., Jacobs S., Wilber J.F., “The human testis: a novel locus for thyrotropin-releasing hormone (TRH) and TRH mRNA,” Trans. Assoc. Am. Physicians 105:222-228 (1992)

• Ambulos N.P. Jr., Kim U.J., Rogers E.J., Lovett P.S., “Constitutive expression of cat-86 associated with a change in the transcription start point,” Gene 105:113-117 (1991)

• Rogers E.J., Kim U.J., Ambulos N.P. Jr., Lovett P.S., “Four codons in the cat-86 leader define a chloramphenicol-sensitive ribosome stall sequence,” J. Bacteriol. 172:110-115 (1990)

• Kim U.J., Ambulos N.P. Jr., Duvall E.J., Lorton M.A., Lovett P.S., “Site in the cat-86 regulatory leader that permits amicetin to induce expression of the gene,” J. Bacteriol. 170:2933-2938 (1988)

• Alexieva Z., Duvall E.J., Ambulos N.P. Jr., Kim U.J., Lovett P.S., “Chloramphenicol induction of cat-86 requires ribosome stalling at a specific site in the leader,” Proc. Natl. Acad. Sci. USA 85:3057-3061 (1988)

• Duvall E.J., Mongkolsuk S., Kim U.J., Lovett P.S., Henkin T.M., Chambliss G.H., “Induction of the chloramphenicol acetyltransferase gene cat-86 through the action of the ribosomal antibiotic amicetin: involvement of a Bacillus subtilis ribosomal component in cat induction,” J. Bacteriol. 161:665-672 (1985)

Areas of Practice (2)

  • Intellectual Property
  • Life Sciences and Emerging Growth Companies

Education & Credentials

Contact Information:
University Attended:
University of Maryland, B.A., Biology; University of Maryland, M.S., Biology; University of Maryland Francis King Carey School of Law, J.D.
Year of First Admission:
United States Court of Appeals for the Federal Circuit; 1995, Maryland; United States Supreme Court; 1998, District of Columbia; United States Patent and Trademark Office
Conversational Korean

Peer Reviews

This lawyer does not have peer reviews.

*Peer Reviews provided before April 15, 2008 are not displayed.

Washington, District of Columbia

Contact Judith U. Kim

Required Fields

Required Fields

By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.